Trial Details

UNKNOWN
Basic Information
Clinical ID c3722
Identifier NCT01629212
Trial Title Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: Tiropramide HCl 100mg|DRUG: Octylonium bromide 20mg
Participant Information
Sponsor Daewoong Pharmaceutical Co. LTD.
City Seoul
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2011-12
Primary Completion Date 2013-02
Completion Date 2013-02